Berger Montague PC Investigates Hims & Hers Health, Inc.'s Board of Directors for Breach of Fiduciary Duty (HIMS)

A law firm is investigating Hims & Hers for possible board-level misconduct.

Risk flags

• ●The investigation itself introduces headline and reputational risk for Hims & Hers, as public disclosure of board-level scrutiny can undermine investor and customer confidence even before any findings are made.
• ●No factual or numerical evidence is provided regarding the alleged misconduct, creating uncertainty about the likelihood, scope, or materiality of any potential breaches. This lack of detail leaves investors unable to assess exposure or probability of adverse outcomes.
• ●Legal proceedings or investigations can result in significant costs, regulatory scrutiny, or operational disruption if substantiated, but the announcement gives no indication of the stage, scope, or potential consequences. The open-ended nature of the inquiry increases the risk of protracted uncertainty.

Bottom line

This announcement signals that Hims & Hers Health, Inc. is under investigation by a major law firm for possible breaches of fiduciary duty, including alleged improper data sharing and billing practices. No evidence or findings are disclosed, and no financial or operational data for Hims & Hers is provided. The only substantiated figures relate to Berger Montague’s legal track record, not the subject of the investigation. Investors cannot assess the likelihood or materiality of any outcome based on the information given. Unless and until the investigation yields concrete findings or legal action, this news is not actionable for investment decisions. The most important takeaway is the introduction of legal and reputational uncertainty for Hims & Hers, with no clarity on scope, timeline, or impact.

Announcement summary

(NYSE:HIMS) Berger Montague PC announced an investigation into the Board of Directors of Hims & Hers Health, Inc. for potential breaches of fiduciary duties owed to the Company and its shareholders. The investigation focuses on whether the Company improperly shared private user health data with advertisers, engaged in deceptive billing practices, and made subscription cancellations unnecessarily difficult. Hims & Hers is headquartered in San Francisco, Calif., and operates a digital health platform connecting individuals with licensed healthcare providers and personalized treatment plans. Berger Montague has secured more than $2.4 billion in 2025 post-trial judgments alone and has recovered over $50 billion for its clients and the classes they have represented. The firm has been active for over 55 years and is headquartered in Philadelphia, with offices in Chicago; Malvern, PA; Minneapolis; San Diego; San Francisco; Toronto, Canada; Washington, D.C.; and Wilmington, DE. Shareholders of Hims & Hers may learn more about this investigation by contacting Berger Montague. No forward-looking projections or financial guidance were disclosed in the announcement.

Disagree with this article?